Intercept Pharmaceuticals Inc (NASDAQ:ICPT)
| 17.21 Delayed Data As of 4:00pm ET |  +0.74 / +4.49%Today’s Change | 11.60 Today|||52-Week Range 38.94 | -30.32% Year-to-Date |
Latest ICPT News | Press Releases
No recent news for Intercept Pharmaceuticals Inc.
Today’s Trading
| Previous close | 16.47 |
| Today’s open | 16.81 |
| Day’s range | 16.37 - 17.26 |
| Volume | 17,897 |
| Average volume (3 months) | 911,523 |
| Market cap | $502.0M |
Data as of 4:00pm ET, 11/30/2021
Growth & Valuation
| Earnings growth (last year) | +23.43% |
| Earnings growth (this year) | +67.71% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +24.08% |
| P/E ratio | NM |
| Price/Sales | 2.60 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRQRProQR Therapeutics N... | +0.16 | +2.32% |
| SMMTSummit Therapeutics ... | +0.03 | +0.59% |
| ---- | ||
| ---- |
Data as of 4:00pm ET, 11/30/2021
Financials
| Next reporting date | February 24, 2022 |
| EPS forecast (this quarter) | -$1.06 |
| Annual revenue (last year) | $312.7M |
| Annual profit (last year) | -$274.9M |
| Net profit margin | -87.91% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
